A. Sayiner (Izmir, Turkey)
Implementation of pneumonia guidelines improves patient management: a three-phase study in internal medicine departments
F. Blasi, I. Iori, A. Bulfoni, S. Corrao, S. Costantino, D. Legnani (Milan, Reggio Emilia, Udine, Palermo, Rome, Italy)
|  |
Local antibiotic guidelines for management of adult community acquired pneumonia in UK hospitals
B. L. Barker, J. Macfarlane, W. S. Lim, J. G. Douglas, J. T. Macfarlane (Nottingham, Dunfermile, Aberdeen, United Kingdom)
|  |
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
J. Bordon, P. Peyrani, G. Brock, J. Ramirez (Washington, DC, Louisville, KY, United States Of America)
| |
Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors
A. Sakamoto, Y. Onoe, T. Mutoh, T. Maeda, N. Oyama, K. Hidaka (Fukuoka, Japan)
| |
Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis
H. Aoki, T. Hisada, T. Ishizuka, N. Sunaga, Y. Shimizu, M. Utsugi, K. Kaira, N. Yanagitani, T. Aomori, K. Yamamoto, Y. Tokue, K. Dobashi, M. Mori (Maebashi, Japan)
| |
The influence of CRB-65 and some clinical and epidemiological factors over approach to community acquired pneumonia
P. Nikolova, Y. Ivanov, E. Borissova, P. Pavlov, T. Popova (Pleven, Bulgaria)
| |
Use of admission criteria in patients with CAP in a district hospital
V. Paschidou, S. Kokkali, B. Knjeginjic, I. Petrou, A. Tsomidis, G. Gougoulias, C. Papakonstantinou (Chalkidiki, Greece)
| |
Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP)
A. Kosma, E. Kosma, A. Lazaridou, V. Randou, E. Kalaitzidou, N. Galanis (Thessaloniki, Greece)
| |
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
M. Mily (Vitebsk, Belarus)
| |
Antimicrobial susceptibility of atypical pathogens
J. Summersgill, J. Ramirez (Louisville, KY, United States Of America)
| |
Efficacy of sequential intravenous (i.v.) to oral (p.o.) moxifloxacin in hospitalized patients with community-acquired pneumonia (CAP) due to m. pneumoniae or chlamydia spp.
J. Garau, A. Torres, D. Haverstock, P. Arvis, S. Choudhri (Barcelona, Spain; West Haven, CT, United States Of America; Puteaux, France; Toronto, ON, Canada)
| |
Comparison of conventional and sequential antibiotic therapy of community-acquired pneumonia with levofloxacin and moxifloxacin
R. Anastasova, O. Georgiev, D. Petrova (Sofia, Bulgaria)
| |
Monotherapy treatment with levofloxacin 500mg per day during 10 days in outpatients in a Legionella pneumophila outbreak in June 2006
B. Fernández, I. Clavera, F. J. Michel, I. Pascal, V. M. Eguía, F. J. Domínguez (Pamplona, Spain)
| |
Community acquired pneumonia in Greece: clinical, laboratory data – adherence to the international guidelines
C. Triantafyllidis, V. Kapordelis, M. Apostolidou, A. Pefanis, D. Orfanidou (Athens, Greece)
| |
Guidelines for CAP and reality in a district hospital
V. Paschidou, S. Kokkali, B. Knjeginjic, I. Petrou, A. Tsomidis, G. Gougoulias, C. Papakonstantinou (Chalkidiki, Greece)
| |
Descriptive study of a Legionella pneumophila pneumonia outbreak in Pamplona in June 2006
B. Fernández, B. Marín, J. A. Cascante, M. Pérez, M. C. Bermejo, P. Cebollero (Pamplona, Spain)
| |
Pneumonia in residents of long-term care facilities
P. G. Dambrava, V. Balasso, A. R. Piñer, E. Cano, M. A. Marcos, M. Sánchez, J. Mensa, A. Torres (Barcelona, Spain)
| |
Lung cancer in long-lasting pneumonia
M. Percinkovski, J. Stojsic, S. Krstic, M. Danilovic (Serbia And Montenegro)
| |
Management of community acquired pneumonia in UK hospitals: a survey of the availability of local guidelines and severity assessment tools
B. L. Barker, J. Macfarlane, W. S. Lim, J. G. Douglas, J. T. Macfarlane (Nottingham, Dunfermile, Aberdeen, United Kingdom)
| |
Community-acquired pneumonia: etiologic changes in a limited geographic area. An 11 year prospective study
I. Suarez, R. Fernandez, G. Rubinos, A. Torres, J. A. Gullon, A. Medina, A. Jimenez, H. Gonzalez, R. Galindo, I. Gonzalez (La Laguna. Santa Cruz de Tenerife, Spain)
| |